These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Polonelli L; Casadevall A; Han Y; Bernardis F; Kirkland TN; Matthews RC; Adriani D; Boccanera M; Burnie JP; Cassone A; Conti S; Cutler JE; Frazzi R; Gregory C; Hodgetts S; Illidge C; Magliani W; Rigg G; Santoni G Med Mycol; 2000; 38 Suppl 1():281-92. PubMed ID: 11204156 [TBL] [Abstract][Full Text] [Related]
6. Effect of Listeria monocytogenes lipids on the immunity of mice against Candida albicans, Cryptococcus neoformans and Trichomonas vaginalis. Jakoniuk P; Jabłońska-Strynkowska W; Musiatowicz B; Borowski J Arch Immunol Ther Exp (Warsz); 1980; 28(3):377-87. PubMed ID: 6778451 [TBL] [Abstract][Full Text] [Related]
7. Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi? Pirofski LA; Casadevall A Zentralbl Bakteriol; 1996 Aug; 284(4):475-95. PubMed ID: 8899968 [TBL] [Abstract][Full Text] [Related]
8. The immune response to fungal infections. Shoham S; Levitz SM Br J Haematol; 2005 Jun; 129(5):569-82. PubMed ID: 15916679 [TBL] [Abstract][Full Text] [Related]
9. Towards a vaccine for Cryptococcus neoformans: principles and caveats. Datta K; Pirofski LA FEMS Yeast Res; 2006 Jun; 6(4):525-36. PubMed ID: 16696648 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain. Wormley FL; Cox GM; Perfect JR Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813 [TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity. Vecchiarelli A; Casadevall A Res Immunol; 1998; 149(4-5):321-33; discussion 500-3. PubMed ID: 9720950 [No Abstract] [Full Text] [Related]
13. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans. Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan. Maitta RW; Datta K; Pirofski LA Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457 [TBL] [Abstract][Full Text] [Related]
15. Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. Nicola AM; Albuquerque P; Martinez LR; Dal-Rosso RA; Saylor C; De Jesus M; Nosanchuk JD; Casadevall A Infect Immun; 2012 Sep; 80(9):3065-76. PubMed ID: 22710871 [TBL] [Abstract][Full Text] [Related]
16. Active and passive immunization against oral Candida albicans infection in a murine model. Farah CS; Ashman RB Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599 [TBL] [Abstract][Full Text] [Related]
18. Antibody response to Cryptococcus neoformans proteins in rodents and humans. Chen LC; Goldman DL; Doering TL; Pirofski La; Casadevall A Infect Immun; 1999 May; 67(5):2218-24. PubMed ID: 10225877 [TBL] [Abstract][Full Text] [Related]
19. Induced humoral immunity and vaccination against major human fungal pathogens. Casadevall A; Feldmesser M; Pirofski LA Curr Opin Microbiol; 2002 Aug; 5(4):386-91. PubMed ID: 12160857 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of immunity in fungal infections. Chute HL Am J Vet Res; 1975 Apr; 36(4 Pt 2):601-2. PubMed ID: 1092228 [No Abstract] [Full Text] [Related] [Next] [New Search]